Prediction of Blood Glucose Levels and Diabetes Complications Using Wearable’s for Type1 Diabetics
DOI:
https://doi.org/10.63682/jns.v14i20S.5368Keywords:
T1DM, T 2DM, LSTM, GRU, Diabetes Prediction, Machine Learning, Artificial Intelligence, Diabetes ComplicationsAbstract
Diabetes leads to early passing and impairment worldwide and affects people despite nation, age and sex. Accurate and timely prediction of blood glucose levels is important for managing diabetes, enabling proactive interventions to prevent hypo- and hyperglycemic events. Though a prediction of glucose level is a critical aspect in the real world, it helps diabetic patients manage their conditions and lowers the risk of developing health complications. This study aims to predict blood glucose values of diabetic patients using LSTM and GRU individual models on D1NAMO dataset. Forecasting of glucose level was carried out by considering diabetic patients CGM recordings additionally with their physical measurements. The comparison of these models for blood glucose forecasting under three evaluation metrics was performed. We successfully implemented our proposed approach for nine type1 diabetic patients and achieved RMSE 0.165, MAE 0.133 and 1.605 MAPE. It has been found that a single layer of GRU with a dense layer is sufficient to obtain good accuracy. Additionally, this paper includes predicting diabetes symptoms based on six glycemic diabetes ranges using SVM.
Downloads
Metrics
References
Madhuri B. Kawarkhe, Dr. Parminder Kaur, "Prediction of Diabetes using Diverse Ensemble Learning classifiers", International conference on Machine Learning and Data Engine ring 2.0 (ICMLDE 2023) , at UPES Dehradun. Procedia Computer Science, ELSEVIER 2024, 235, pp. 403–413.DOI:10.1016/j.procs.2024.04.040.
Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes related complications. PhysTher. 2008 Nov;88(11):1254-64. doi: 10.2522/ptj.20080020. Epub 2008 Sep 18. PMID: 18801858; PMCID: PMC3870323.
Shreyaswi Sathyanath, Rashmi Kundapur, R. Deepthi, Santhosh N. Poojary, SathvikRai, BhaveshModi, Deepak Saxena, An economic evaluation of diabetes mellitus in India: A systematic review, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, Volume 16, Issue 11, 2022, 102641, ISSN 1871-4021,doi.org/10.1016/j.dsx.2022.102641.
International Diabetes Federation (IDF). IDF Diabetes Atlas. 2021. Available online: https://diabetesatlas.org/atlas/tenth-edition/ (accessed on 20 September 2022).
Munoz-Organero M. Deep Physiological Model for Blood Glucose Prediction in T1DMPatients. Sensors (Basel). 2020 Jul 13;20(14):3896. doi: 10.3390/s20143896. PMID:32668724; PMCID: PMC7412558.
Han, Yechan& Kim, Dae-Yeon& Woo, Jiyoung& Kim, Jaeyun. (2024). Glu-Ensemble:An ensemble deep learning framework for blood glucose forecasting in type 2 diabetespatients. Heliyon. 10. e29030. 10.1016/j.heliyon.2024.e29030.
Zaidi, S.M.A., Chandola, V., Ibrahim, M. et al. Multi-step ahead predictive model forblood glucose concentrations of type-1 diabetic patients. Sci Rep 11, 24332 (2021).https://doi.org/10.1038/s41598-021-03341-5.
Zarkogianni K, Mougiakakou SG, Prountzou A, Vazeou A, Bartsocas CS, Nikita KS. Aninsulin infusion advisory system for type 1 diabetes patients based on non-linear modelpredictive control methods. AnnuIntConf IEEE Eng Med Biol Soc. 2007;2007:5972-5.doi: 10.1109/IEMBS.2007.4353708. PMID: 18003374.
Zhu T, Li K, Herrero P, Georgiou P. Personalized Blood Glucose Prediction for Type 1Diabetes Using Evidential Deep Learning and Meta-Learning. IEEE Trans Biomed Eng.2023 Jan;70(1):193-204. doi: 10.1109/TBME.2022.3187703. Epub 2022 Dec 26. PMID:35776825.
Fabien Dubosson, Jean-Eudes Ranvier, Stefano Bromuri, Jean-Paul Calbimonte, JuanRuiz, Michael Schumacher,The open D1NAMO dataset: A multi-modal dataset for research on non-invasive type 1 diabetes management, Informatics in MedicineUnlocked, Volume 13, 2018, Pages 92-100, ISSN 2352-9148, https://doi.org/10.1016/j.imu.2018.09.003.
Takoua Hamdi, Jaouher Ben Ali, Véronique Di Costanzo, FarhatFnaiech, Eric Moreau, Jean-Marc Ginoux, Accurate prediction of continuous blood glucose based on supportvector regression and differential evolution algorithm, Biocybernetics and Biomedical Engineering, Volume 38, Issue 2, 2018, ISSN 0208-5216, https://doi.org/10.1016/j.bbe.2018.02.005.
Cryer PE. Hypoglycemia in diabetes. Pathophysiology, prevalence, and prevention. Am J Med. 2004;116(Suppl 3A):10S-18S.
Frier BM. Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications.Nat Rev Endocrinol. 2014;10(12):711-722.
American Diabetes Association (ADA). Standards of Medical Care in Diabetes—2020. DiabetesCare. 2020;43(Suppl 1)
ADA. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33 (Suppl1)
Vinik AI, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2009;32(1):22-30.
Muller LM, et al. Increased risk of common infections in patients with type 1 and type 2diabetes mellitus. Clin Infect Dis. 2005;41(3):281-288.
DCCT Research Group. The effect of intensive treatment of diabetes on the developmentand progression of long-term complications in insulin-dependent diabetes mellitus. NEngl J Med. 1993;329(14):977-986.
Stratton IM, et al. Association of glycaemia with macrovascular and microvascularcomplications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ.2000;321(7258):405-412.
Kitabchi AE, et al. Hyperglycemic crises in adult patients with diabetes. Diabetes Care.2009;32(7):1335-1343.
Bhimireddy, Ananth, Sinha, Priyanshu, Oluwalade, Bolu, Gichoya, Judy W, andPurkayastha, Saptarshi. Blood Glucose Level Prediction as Time-Series Modeling usingSequence-to-Sequence Neural Networks. Retrieved fromhttps://par.nsf.gov/biblio/10188463. CEUR workshop proceedings.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
